Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 159 entries
View as:

Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648063 Org: User:
Start: 11/30/05 End: 01/31/06 Due: 01/31/07

Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649129 Org: User:
Start: 07/31/02 End: 08/31/02 Due: 08/31/03

Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649038 Org: User:
Start: 12/31/02 End: 12/31/02 Due: 12/31/03

Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647959 Org: User:
Start: 03/31/06 End: 04/30/06 Due: 04/30/07

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649662 Org: User:
Start: 10/31/05 End: 10/31/05 Due: 10/31/06

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02109185 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649935 Org: User:
Start: 05/31/05 End: 06/30/05 Due: 06/30/06

Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649636 Org: User:
Start: 02/28/06 End: 04/30/06 Due: 04/30/07

Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg

Phase: N/A Priority: Normal
NCT ID: NCT00985660 Org: User:
Start: 06/30/07 End: 07/31/07 Due: 07/31/08

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Phase: N/A Priority: Normal
NCT ID: NCT00648960 Org: User:
Start: 07/31/03 End: 07/31/03 Due: 07/31/04

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

Phase: N/A Priority: Normal
NCT ID: NCT01012934 Org: User:
Start: 07/31/02 End: 08/31/02 Due: 08/31/03

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648024 Org: User:
Start: 01/31/03 End: 01/31/03 Due: 01/31/04

Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00650481 Org: User:
Start: 12/31/02 End: 01/31/03 Due: 01/31/04

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648947 Org: User:
Start: 12/31/04 End: 12/31/04 Due: 12/31/05

Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647816 Org: User:
Start: 09/30/05 End: 09/30/05 Due: 09/30/06

Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649779 Org: User:
Start: 09/30/05 End: 10/31/05 Due: 10/31/06

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647673 Org: User:
Start: 01/31/06 End: 02/28/06 Due: 02/28/07

Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648180 Org: User:
Start: 07/31/05 End: 08/31/05 Due: 08/31/06

Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

Phase: N/A Priority: Normal
NCT ID: NCT00647751 Org: User:
Start: 08/31/04 End: 08/31/04 Due: 08/31/05

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649948 Org: User:
Start: 02/29/04 End: 06/30/04 Due: 06/30/05

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648050 Org: User:
Start: 03/31/06 End: 03/31/06 Due: 03/31/07

Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649727 Org: User:
Start: 07/31/02 End: 08/31/02 Due: 08/31/03

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00648622 Org: User:
Start: 04/30/04 End: 04/30/04 Due: 04/30/05

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

Phase: N/A Priority: Normal
NCT ID: NCT00649987 Org: User:
Start: 09/30/05 End: 10/31/05 Due: 10/31/06

MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04633564 Org: User:
Start: 01/21/17 End: 11/22/19 Due: 11/22/20